Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2

BACKGROUND: Neurofibromatosis type 2 (NF2) is an autosomal dominant genetic disease characterized by development of schwannomas on the VIIIth (vestibular) cranial nerves. Bromodomain and extra-terminal domain (BET) proteins regulate gene transcription and their activity is required in a variety of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Doherty, Joanne, Mandati, Vinay, González Rodriguez, Maria A, Troutman, Scott, Shepard, Alyssa, Harbaugh, David, Brody, Rachel, Miller, Douglas C, Kareta, Michael S, Kissil, Joseph L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Basic and Translational Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278623/
https://www.ncbi.nlm.nih.gov/pubmed/35855490
http://dx.doi.org/10.1093/noajnl/vdac072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278623/
https://www.ncbi.nlm.nih.gov/pubmed/35855490
http://dx.doi.org/10.1093/noajnl/vdac072

Ejemplares similares